Increased cortical extracellular adenosine correlates with seizure termination
Jamie J Van Gompel1, Mark R Bower, Gregory A Worrell
1Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota, U.S.A.
Epilepsia
|February 4, 2014
Summary
Extracellular adenosine levels significantly increase just before seizure termination in both animal models and human epilepsy patients. This suggests adenosine plays a crucial role in ending seizures, offering new therapeutic insights.
Area of Science:
- Neuroscience
- Biochemistry
- Epilepsy Research
Background:
- Seizures are defined by electrographic features, but neurotransmitter dynamics during seizures are poorly understood.
- Adenosine shows promise in terminating seizures, evidenced by animal models and human microdialysis studies.
- Previous human studies had temporal limitations in measuring adenosine during seizures.
Purpose of the Study:
- To test the hypothesis that extracellular adenosine concentrations increase during seizure termination.
- To investigate periictal adenosine dynamics using high-temporal-resolution electrochemistry.
- To correlate adenosine levels with electrographic seizure events in real-time.
Main Methods:
- Utilized an acute cortical epilepsy model in swine (n=45) and studied 10 human epilepsy patients during intraoperative electrocorticography (ECoG).
- Employed Wireless Instantaneous Neurotransmitter Concentration Sensor (WINCS)-based fast scan cyclic voltammetry (FSCV) and fixed potential amperometry for adenosine measurement.
- Collected simultaneous ECoG and electrochemical data to capture periictal neurotransmitter changes.
Main Results:
- Demonstrated an average adenosine increase of 260% prior to electrographic seizure termination in swine.
- Observed adenosine elevation occurring seconds before seizure termination using both amperometry (7.5 ± 16.9 s) and FSCV (2.6 ± 11.2 s).
- Confirmed similar adenosine elevation preceding seizure termination in a human patient using FSCV.
Conclusions:
- Simultaneous ECoG and electrochemical recordings support the hypothesis of rising adenosine levels before seizure termination.
- Findings suggest adenosine may be intrinsically responsible for seizure termination.
- Future intraoperative WINCS-based FSCV recordings can further elucidate the adenosine-seizure relationship.
Related Concept Videos
Seizures: Classification
2.5K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: Potassium Channel Activators
1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiepileptic Drugs: Glutamate Antagonists
1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K


